Pfizer Patient Assistance Program for IbranceThis Patient Assistance Program from Pfizer, specifically for Ibrance, carries the primary objective of supplying financial assistance coupled with support to patients prescribed this medication.Category: HEALTH CARECategory: BREAST CANCERCategory: PFIZERCategory: IBRANCECategory: PATIENT ASSISTANCE PROGRAM
Evaluation of Pfizer's BRAFTOVI® in Targeting BRAF-Mutant MelanomaPfizer Braftovi, a kinase inhibitor recently approved by the U.S. FDA, provides treatment options for patients with metastatic or unresectable melanoma harboring a BRAF V600E or V600K mutation.Category: ONCOLOGYCategory: MELANOMACategory: PFIZERCategory: BRAFTOVI
Pfizer Oncology Together: A Support Program for Patients Taking IBRANCEIBRANCE (palbociclib) is a prescription medicine that is used to treat adults with hormone receptor-positive (HR+)...Category: ONCOLOGYCategory: IBRANCECategory: PFIZER
